Calithera Biosciences Inc (CALA) Return on Assets ROA from the fourth quarter of 2022 to fourth quarter of 2021 and for the year 2022, Average High and Low, Fundamental Ratios from Dec 31 2022 to Dec 31 2021 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Calithera Biosciences Inc   (NASDAQ: CALA)


Calithera Biosciences Inc 's ROA from the fourth quarter of 2022 to the fourth quarter of 2021 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Calithera Biosciences Inc 's ROA in the fourth quarter of 2022?
Calithera Biosciences Inc recorded a cumulative net loss of $-21 million during 12 months ending in the fourth quarter of 2022, resulting in a negative return on assets (ROA) of -54.95%.

However, within the Healthcare sector 851 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the third quarter of 2022 from 5460 to 5508.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter		 (Jun 30 2022)
II. Quarter		 (Mar 31 2022)
I. Quarter		 (Dec 31 2021)
IV. Quarter
Y / Y Total Assets Change -55.69 % -59.06 % -54.46 % -55.28 % -73.46 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million -21 -85 -86 -109 -115
Return On Assets (TTM) -54.95 % -179.12 % -143.13 % -147.99 % -130.52 %
CALA's Total Ranking # 5508 # 5460 # 5499 # 5438 # 5755
Total Assets (TTM) in million 28 36 44 48 62
Seq. Total Assets Change -22.72 % -18.15 % -9.16 % -22.88 % -28.6 %
Seq. Net Income Change - - - - -

CALA's 5 Years Annual ROA >> Back to CALA Management Effectiveness >> Compare CALA ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 384
Sector # 852
Overall # 5341

Return On Assets Statistics
High Average Low
14.12 %
-56.37 %
-171.89 %
(Sep 30 2015)   (Sep 30 2022)





Financial Statements
Calithera Biosciences Inc 's Assets $ 28 million CALA's Balance sheet
Calithera Biosciences Inc 's Income $ -6 million Quarterly CALA's Income Statement
CALA's Income by Division See CALA's Income by Division



Annual Return On Assets (Dec 31 2022)
FY 2022		 (Dec 31 2021)
FY 2021		 (Dec 31 2020)
FY 2020		 (Dec 31 2019)
FY 2019		 (Dec 31 2018)
FY 2018
Y / Y Total Assets Change -55.69 % -48.03 % -29 % 18.25 % -25.84 %
Total Assets in million 28 62 120 169 143
Y / Y Net Income Change - - - - -
Net Income in million -21 -115 -90 -90 -55
Annual Return On Assets -77.14 % -184.8 % -75.22 % -53.24 % -38.28 %

CALA's 5 Years Annual ROA >> Back to CALA Management Effectiveness >> Compare CALA ROA to its Competitors



More Return On Assets Ratios
CALA's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
CALA's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for CALA's Competitors
Subscribers only: Roa for Calithera Biosciences Inc 's Suppliers
Subscribers only: Return On Assets for CALA's Customers

You may also want to know
CALA's Roi CALA's Inventory Turnover Ratio CALA's Growth Rates CALA's Dividend Comparisons
CALA's Profitability Ratios CALA's Asset Turnover Ratio CALA's Dividend Growth
CALA's Roe CALA's Valuation Ratios CALA's Financial Strength Ratios CALA's Dividend Payout Ratio



Companies with similar Return On Assets at Dec 31 2022, within Healthcare Sector ROA

Date modified: 2026-09-08T15:10:53+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.